GKOS/ 10/27/2025 · 7:35 AM Wells Fargo Upgrades Glaukos: Hidden Growth Driver Spotted Wells Fargo raises Glaukos price target to $120, citing Epioxa as underappreciated growth catalyst beyond iDose focus. Stock upgrade to Overweight.
